カテゴリー： 世界, 医療/バイオ, QYResearch

転移性脊椎腫瘍手術の世界市場インサイト・予測（～2028年）

【英語タイトル】Global Metastases Spinal Tumor Surgery Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX09252）・商品コード：QY22JLX09252
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：111
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医療
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、転移性脊椎腫瘍手術のグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に転移性脊椎腫瘍手術の世界市場のxxx％を占める「低侵襲手術」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
転移性脊椎腫瘍手術の中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパの転移性脊椎腫瘍手術市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

転移性脊椎腫瘍手術のグローバル主要企業には、Stryker、Johnson & Johnson、Heraeus Medical、Smith & Nephew、Medtronic、Globus Medical、DJO Global、Tecres、Merit Medical、Teknimed、G-21、OSARTIS GmbH、IZI Medicalなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

転移性脊椎腫瘍手術市場は、種類と用途によって区分されます。世界の転移性脊椎腫瘍手術市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
低侵襲手術、開腹手術

【用途別セグメント】
病院、専門クリニック

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- 転移性脊椎腫瘍手術製品概要
- 種類別市場（低侵襲手術、開腹手術）
- 用途別市場（病院、専門クリニック）
- 調査の目的
・エグゼクティブサマリー
- 世界の転移性脊椎腫瘍手術販売量予測2017-2028
- 世界の転移性脊椎腫瘍手術売上予測2017-2028
- 転移性脊椎腫瘍手術の地域別販売量
- 転移性脊椎腫瘍手術の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別転移性脊椎腫瘍手術販売量
- 主要メーカー別転移性脊椎腫瘍手術売上
- 主要メーカー別転移性脊椎腫瘍手術価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（低侵襲手術、開腹手術）
- 転移性脊椎腫瘍手術の種類別販売量
- 転移性脊椎腫瘍手術の種類別売上
- 転移性脊椎腫瘍手術の種類別価格
・用途別市場規模（病院、専門クリニック）
- 転移性脊椎腫瘍手術の用途別販売量
- 転移性脊椎腫瘍手術の用途別売上
- 転移性脊椎腫瘍手術の用途別価格
・北米市場
- 北米の転移性脊椎腫瘍手術市場規模（種類別、用途別）
- 主要国別の転移性脊椎腫瘍手術市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパの転移性脊椎腫瘍手術市場規模（種類別、用途別）
- 主要国別の転移性脊椎腫瘍手術市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋の転移性脊椎腫瘍手術市場規模（種類別、用途別）
- 主要国別の転移性脊椎腫瘍手術市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米の転移性脊椎腫瘍手術市場規模（種類別、用途別）
- 主要国別の転移性脊椎腫瘍手術市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカの転移性脊椎腫瘍手術市場規模（種類別、用途別）
- 主要国別の転移性脊椎腫瘍手術市場規模（トルコ、サウジアラビア）
・企業情報
Stryker、Johnson & Johnson、Heraeus Medical、Smith & Nephew、Medtronic、Globus Medical、DJO Global、Tecres、Merit Medical、Teknimed、G-21、OSARTIS GmbH、IZI Medical
・産業チェーン及び販売チャネル分析
- 転移性脊椎腫瘍手術の産業チェーン分析
- 転移性脊椎腫瘍手術の原材料
- 転移性脊椎腫瘍手術の生産プロセス
- 転移性脊椎腫瘍手術の販売及びマーケティング
- 転移性脊椎腫瘍手術の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 転移性脊椎腫瘍手術の産業動向
- 転移性脊椎腫瘍手術のマーケットドライバー
- 転移性脊椎腫瘍手術の課題
- 転移性脊椎腫瘍手術の阻害要因
・主な調査結果

Market Analysis and Insights: Global Metastases Spinal Tumor Surgery Market
The global Metastases Spinal Tumor Surgery market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, Minimally Invasive Surgery accounting for % of the Metastases Spinal Tumor Surgery global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Hospital segment is altered to an % CAGR throughout this forecast period.
China Metastases Spinal Tumor Surgery market size is valued at US$ million in 2021, while the North America and Europe Metastases Spinal Tumor Surgery are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Metastases Spinal Tumor Surgery landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastases Spinal Tumor Surgery market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastases Spinal Tumor Surgery market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastases Spinal Tumor Surgery market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastases Spinal Tumor Surgery market.
Global Metastases Spinal Tumor Surgery Scope and Market Size
Metastases Spinal Tumor Surgery market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Metastases Spinal Tumor Surgery market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Minimally Invasive Surgery
Open Surgery
Segment by Application
Hospital
Specialty Clinic
By Company
Stryker
Johnson & Johnson
Heraeus Medical
Smith & Nephew
Medtronic
Globus Medical
DJO Global
Tecres
Merit Medical
Teknimed
G-21
OSARTIS GmbH
IZI Medical
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

❖ レポートの目次 ❖

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastases Spinal Tumor Surgery Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Minimally Invasive Surgery
1.2.3 Open Surgery
1.3 Market by Application
1.3.1 Global Metastases Spinal Tumor Surgery Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Specialty Clinic
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Metastases Spinal Tumor Surgery Market Perspective (2017-2028)
2.2 Metastases Spinal Tumor Surgery Growth Trends by Region
2.2.1 Metastases Spinal Tumor Surgery Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Metastases Spinal Tumor Surgery Historic Market Size by Region (2017-2022)
2.2.3 Metastases Spinal Tumor Surgery Forecasted Market Size by Region (2023-2028)
2.3 Metastases Spinal Tumor Surgery Market Dynamics
2.3.1 Metastases Spinal Tumor Surgery Industry Trends
2.3.2 Metastases Spinal Tumor Surgery Market Drivers
2.3.3 Metastases Spinal Tumor Surgery Market Challenges
2.3.4 Metastases Spinal Tumor Surgery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Metastases Spinal Tumor Surgery Players by Revenue
3.1.1 Global Top Metastases Spinal Tumor Surgery Players by Revenue (2017-2022)
3.1.2 Global Metastases Spinal Tumor Surgery Revenue Market Share by Players (2017-2022)
3.2 Global Metastases Spinal Tumor Surgery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Metastases Spinal Tumor Surgery Revenue
3.4 Global Metastases Spinal Tumor Surgery Market Concentration Ratio
3.4.1 Global Metastases Spinal Tumor Surgery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastases Spinal Tumor Surgery Revenue in 2021
3.5 Metastases Spinal Tumor Surgery Key Players Head office and Area Served
3.6 Key Players Metastases Spinal Tumor Surgery Product Solution and Service
3.7 Date of Enter into Metastases Spinal Tumor Surgery Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Metastases Spinal Tumor Surgery Breakdown Data by Type
4.1 Global Metastases Spinal Tumor Surgery Historic Market Size by Type (2017-2022)
4.2 Global Metastases Spinal Tumor Surgery Forecasted Market Size by Type (2023-2028)
5 Metastases Spinal Tumor Surgery Breakdown Data by Application
5.1 Global Metastases Spinal Tumor Surgery Historic Market Size by Application (2017-2022)
5.2 Global Metastases Spinal Tumor Surgery Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Metastases Spinal Tumor Surgery Market Size (2017-2028)
6.2 North America Metastases Spinal Tumor Surgery Market Size by Type
6.2.1 North America Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
6.2.2 North America Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
6.2.3 North America Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
6.3 North America Metastases Spinal Tumor Surgery Market Size by Application
6.3.1 North America Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
6.3.2 North America Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
6.3.3 North America Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
6.4 North America Metastases Spinal Tumor Surgery Market Size by Country
6.4.1 North America Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
6.4.2 North America Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
6.4.3 United States
6.4.4 Canada
7 Europe
7.1 Europe Metastases Spinal Tumor Surgery Market Size (2017-2028)
7.2 Europe Metastases Spinal Tumor Surgery Market Size by Type
7.2.1 Europe Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
7.2.2 Europe Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
7.2.3 Europe Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
7.3 Europe Metastases Spinal Tumor Surgery Market Size by Application
7.3.1 Europe Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
7.3.2 Europe Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
7.3.3 Europe Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
7.4 Europe Metastases Spinal Tumor Surgery Market Size by Country
7.4.1 Europe Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
7.4.2 Europe Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size (2017-2028)
8.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Type
8.2.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
8.3 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Application
8.3.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
8.4 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Region
8.4.1 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Metastases Spinal Tumor Surgery Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Metastases Spinal Tumor Surgery Market Size (2017-2028)
9.2 Latin America Metastases Spinal Tumor Surgery Market Size by Type
9.2.1 Latin America Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
9.2.2 Latin America Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
9.2.3 Latin America Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
9.3 Latin America Metastases Spinal Tumor Surgery Market Size by Application
9.3.1 Latin America Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
9.3.2 Latin America Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
9.3.3 Latin America Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
9.4 Latin America Metastases Spinal Tumor Surgery Market Size by Country
9.4.1 Latin America Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
9.4.2 Latin America Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size (2017-2028)
10.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Type
10.2.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Metastases Spinal Tumor Surgery Market Share by Type (2017-2028)
10.3 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Application
10.3.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Metastases Spinal Tumor Surgery Market Share by Application (2017-2028)
10.4 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Country
10.4.1 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Metastases Spinal Tumor Surgery Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Stryker
11.1.1 Stryker Company Details
11.1.2 Stryker Business Overview
11.1.3 Stryker Metastases Spinal Tumor Surgery Introduction
11.1.4 Stryker Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.1.5 Stryker Recent Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Metastases Spinal Tumor Surgery Introduction
11.2.4 Johnson & Johnson Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.2.5 Johnson & Johnson Recent Developments
11.3 Heraeus Medical
11.3.1 Heraeus Medical Company Details
11.3.2 Heraeus Medical Business Overview
11.3.3 Heraeus Medical Metastases Spinal Tumor Surgery Introduction
11.3.4 Heraeus Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.3.5 Heraeus Medical Recent Developments
11.4 Smith & Nephew
11.4.1 Smith & Nephew Company Details
11.4.2 Smith & Nephew Business Overview
11.4.3 Smith & Nephew Metastases Spinal Tumor Surgery Introduction
11.4.4 Smith & Nephew Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.4.5 Smith & Nephew Recent Developments
11.5 Medtronic
11.5.1 Medtronic Company Details
11.5.2 Medtronic Business Overview
11.5.3 Medtronic Metastases Spinal Tumor Surgery Introduction
11.5.4 Medtronic Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.5.5 Medtronic Recent Developments
11.6 Globus Medical
11.6.1 Globus Medical Company Details
11.6.2 Globus Medical Business Overview
11.6.3 Globus Medical Metastases Spinal Tumor Surgery Introduction
11.6.4 Globus Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.6.5 Globus Medical Recent Developments
11.7 DJO Global
11.7.1 DJO Global Company Details
11.7.2 DJO Global Business Overview
11.7.3 DJO Global Metastases Spinal Tumor Surgery Introduction
11.7.4 DJO Global Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.7.5 DJO Global Recent Developments
11.8 Tecres
11.8.1 Tecres Company Details
11.8.2 Tecres Business Overview
11.8.3 Tecres Metastases Spinal Tumor Surgery Introduction
11.8.4 Tecres Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.8.5 Tecres Recent Developments
11.9 Merit Medical
11.9.1 Merit Medical Company Details
11.9.2 Merit Medical Business Overview
11.9.3 Merit Medical Metastases Spinal Tumor Surgery Introduction
11.9.4 Merit Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.9.5 Merit Medical Recent Developments
11.10 Teknimed
11.10.1 Teknimed Company Details
11.10.2 Teknimed Business Overview
11.10.3 Teknimed Metastases Spinal Tumor Surgery Introduction
11.10.4 Teknimed Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.10.5 Teknimed Recent Developments
11.11 G-21
11.11.1 G-21 Company Details
11.11.2 G-21 Business Overview
11.11.3 G-21 Metastases Spinal Tumor Surgery Introduction
11.11.4 G-21 Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.11.5 G-21 Recent Developments
11.12 OSARTIS GmbH
11.12.1 OSARTIS GmbH Company Details
11.12.2 OSARTIS GmbH Business Overview
11.12.3 OSARTIS GmbH Metastases Spinal Tumor Surgery Introduction
11.12.4 OSARTIS GmbH Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.12.5 OSARTIS GmbH Recent Developments
11.13 IZI Medical
11.13.1 IZI Medical Company Details
11.13.2 IZI Medical Business Overview
11.13.3 IZI Medical Metastases Spinal Tumor Surgery Introduction
11.13.4 IZI Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022)
11.13.5 IZI Medical Recent Developments
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Tables
Table 1. Global Metastases Spinal Tumor Surgery Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Minimally Invasive Surgery
Table 3. Key Players of Open Surgery
Table 4. Global Metastases Spinal Tumor Surgery Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 5. Global Metastases Spinal Tumor Surgery Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 6. Global Metastases Spinal Tumor Surgery Market Size by Region (2017-2022) & (US$ Million)
Table 7. Global Metastases Spinal Tumor Surgery Market Share by Region (2017-2022)
Table 8. Global Metastases Spinal Tumor Surgery Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 9. Global Metastases Spinal Tumor Surgery Market Share by Region (2023-2028)
Table 10. Metastases Spinal Tumor Surgery Market Trends
Table 11. Metastases Spinal Tumor Surgery Market Drivers
Table 12. Metastases Spinal Tumor Surgery Market Challenges
Table 13. Metastases Spinal Tumor Surgery Market Restraints
Table 14. Global Metastases Spinal Tumor Surgery Revenue by Players (2017-2022) & (US$ Million)
Table 15. Global Metastases Spinal Tumor Surgery Revenue Share by Players (2017-2022)
Table 16. Global Top Metastases Spinal Tumor Surgery by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastases Spinal Tumor Surgery as of 2021)
Table 17. Ranking of Global Top Metastases Spinal Tumor Surgery Companies by Revenue (US$ Million) in 2021
Table 18. Global 5 Largest Players Market Share by Metastases Spinal Tumor Surgery Revenue (CR5 and HHI) & (2017-2022)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Metastases Spinal Tumor Surgery Product Solution and Service
Table 21. Date of Enter into Metastases Spinal Tumor Surgery Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Metastases Spinal Tumor Surgery Market Size by Type (2017-2022) & (US$ Million)
Table 24. Global Metastases Spinal Tumor Surgery Revenue Market Share by Type (2017-2022)
Table 25. Global Metastases Spinal Tumor Surgery Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 26. Global Metastases Spinal Tumor Surgery Revenue Market Share by Type (2023-2028)
Table 27. Global Metastases Spinal Tumor Surgery Market Size by Application (2017-2022) & (US$ Million)
Table 28. Global Metastases Spinal Tumor Surgery Revenue Share by Application (2017-2022)
Table 29. Global Metastases Spinal Tumor Surgery Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 30. Global Metastases Spinal Tumor Surgery Revenue Share by Application (2023-2028)
Table 31. North America Metastases Spinal Tumor Surgery Market Size by Type (2017-2022) & (US$ Million)
Table 32. North America Metastases Spinal Tumor Surgery Market Size by Type (2023-2028) & (US$ Million)
Table 33. North America Metastases Spinal Tumor Surgery Market Size by Application (2017-2022) & (US$ Million)
Table 34. North America Metastases Spinal Tumor Surgery Market Size by Application (2023-2028) & (US$ Million)
Table 35. North America Metastases Spinal Tumor Surgery Market Size by Country (2017-2022) & (US$ Million)
Table 36. North America Metastases Spinal Tumor Surgery Market Size by Country (2023-2028) & (US$ Million)
Table 37. Europe Metastases Spinal Tumor Surgery Market Size by Type (2017-2022) & (US$ Million)
Table 38. Europe Metastases Spinal Tumor Surgery Market Size by Type (2023-2028) & (US$ Million)
Table 39. Europe Metastases Spinal Tumor Surgery Market Size by Application (2017-2022) & (US$ Million)
Table 40. Europe Metastases Spinal Tumor Surgery Market Size by Application (2023-2028) & (US$ Million)
Table 41. Europe Metastases Spinal Tumor Surgery Market Size by Country (2017-2022) & (US$ Million)
Table 42. Europe Metastases Spinal Tumor Surgery Market Size by Country (2023-2028) & (US$ Million)
Table 43. Asia Pacific Metastases Spinal Tumor Surgery Market Size by Type (2017-2022) & (US$ Million)
Table 44. Asia Pacific Metastases Spinal Tumor Surgery Market Size by Type (2023-2028) & (US$ Million)
Table 45. Asia Pacific Metastases Spinal Tumor Surgery Market Size by Application (2017-2022) & (US$ Million)
Table 46. Asia Pacific Metastases Spinal Tumor Surgery Market Size by Application (2023-2028) & (US$ Million)
Table 47. Asia Pacific Metastases Spinal Tumor Surgery Market Size by Region (2017-2022) & (US$ Million)
Table 48. Asia Pacific Metastases Spinal Tumor Surgery Market Size by Region (2023-2028) & (US$ Million)
Table 49. Latin America Metastases Spinal Tumor Surgery Market Size by Type (2017-2022) & (US$ Million)
Table 50. Latin America Metastases Spinal Tumor Surgery Market Size by Type (2023-2028) & (US$ Million)
Table 51. Latin America Metastases Spinal Tumor Surgery Market Size by Application (2017-2022) & (US$ Million)
Table 52. Latin America Metastases Spinal Tumor Surgery Market Size by Application (2023-2028) & (US$ Million)
Table 53. Latin America Metastases Spinal Tumor Surgery Market Size by Country (2017-2022) & (US$ Million)
Table 54. Latin America Metastases Spinal Tumor Surgery Market Size by Country (2023-2028) & (US$ Million)
Table 55. Middle East and Africa Metastases Spinal Tumor Surgery Market Size by Type (2017-2022) & (US$ Million)
Table 56. Middle East and Africa Metastases Spinal Tumor Surgery Market Size by Type (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Metastases Spinal Tumor Surgery Market Size by Application (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Metastases Spinal Tumor Surgery Market Size by Application (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Metastases Spinal Tumor Surgery Market Size by Country (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Metastases Spinal Tumor Surgery Market Size by Country (2023-2028) & (US$ Million)
Table 61. Stryker Company Details
Table 62. Stryker Business Overview
Table 63. Stryker Metastases Spinal Tumor Surgery Product
Table 64. Stryker Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 65. Stryker Recent Developments
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Metastases Spinal Tumor Surgery Product
Table 69. Johnson & Johnson Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 70. Johnson & Johnson Recent Developments
Table 71. Heraeus Medical Company Details
Table 72. Heraeus Medical Business Overview
Table 73. Heraeus Medical Metastases Spinal Tumor Surgery Product
Table 74. Heraeus Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 75. Heraeus Medical Recent Developments
Table 76. Smith & Nephew Company Details
Table 77. Smith & Nephew Business Overview
Table 78. Smith & Nephew Metastases Spinal Tumor Surgery Product
Table 79. Smith & Nephew Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 80. Smith & Nephew Recent Developments
Table 81. Medtronic Company Details
Table 82. Medtronic Business Overview
Table 83. Medtronic Metastases Spinal Tumor Surgery Product
Table 84. Medtronic Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 85. Medtronic Recent Developments
Table 86. Globus Medical Company Details
Table 87. Globus Medical Business Overview
Table 88. Globus Medical Metastases Spinal Tumor Surgery Product
Table 89. Globus Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 90. Globus Medical Recent Developments
Table 91. DJO Global Company Details
Table 92. DJO Global Business Overview
Table 93. DJO Global Metastases Spinal Tumor Surgery Product
Table 94. DJO Global Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 95. DJO Global Recent Developments
Table 96. Tecres Company Details
Table 97. Tecres Business Overview
Table 98. Tecres Metastases Spinal Tumor Surgery Product
Table 99. Tecres Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 100. Tecres Recent Developments
Table 101. Merit Medical Company Details
Table 102. Merit Medical Business Overview
Table 103. Merit Medical Metastases Spinal Tumor Surgery Product
Table 104. Merit Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 105. Merit Medical Recent Developments
Table 106. Teknimed Company Details
Table 107. Teknimed Business Overview
Table 108. Teknimed Metastases Spinal Tumor Surgery Product
Table 109. Teknimed Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 110. Teknimed Recent Developments
Table 111. G-21 Company Details
Table 112. G-21 Business Overview
Table 113. G-21 Metastases Spinal Tumor Surgery Product
Table 114. G-21 Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 115. G-21 Recent Developments
Table 116. OSARTIS GmbH Company Details
Table 117. OSARTIS GmbH Business Overview
Table 118. OSARTIS GmbH Metastases Spinal Tumor Surgery Product
Table 119. OSARTIS GmbH Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 120. OSARTIS GmbH Recent Developments
Table 121. IZI Medical Company Details
Table 122. IZI Medical Business Overview
Table 123. IZI Medical Metastases Spinal Tumor Surgery Product
Table 124. IZI Medical Revenue in Metastases Spinal Tumor Surgery Business (2017-2022) & (US$ Million)
Table 125. IZI Medical Recent Developments
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastases Spinal Tumor Surgery Market Share by Type: 2021 VS 2028
Figure 2. Minimally Invasive Surgery Features
Figure 3. Open Surgery Features
Figure 4. Global Metastases Spinal Tumor Surgery Market Share by Application: 2021 VS 2028
Figure 5. Hospital Case Studies
Figure 6. Specialty Clinic Case Studies
Figure 7. Metastases Spinal Tumor Surgery Report Years Considered
Figure 8. Global Metastases Spinal Tumor Surgery Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 9. Global Metastases Spinal Tumor Surgery Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Metastases Spinal Tumor Surgery Market Share by Region: 2021 VS 2028
Figure 11. Global Metastases Spinal Tumor Surgery Market Share by Players in 2021
Figure 12. Global Top Metastases Spinal Tumor Surgery Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Metastases Spinal Tumor Surgery as of 2021)
Figure 13. The Top 10 and 5 Players Market Share by Metastases Spinal Tumor Surgery Revenue in 2021
Figure 14. North America Metastases Spinal Tumor Surgery Market Size YoY (2017-2028) & (US$ Million)
Figure 15. North America Metastases Spinal Tumor Surgery Market Size Market Share by Type (2017-2028)
Figure 16. North America Metastases Spinal Tumor Surgery Market Size Market Share by Application (2017-2028)
Figure 17. North America Metastases Spinal Tumor Surgery Market Size Share by Country (2017-2028)
Figure 18. United States Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Metastases Spinal Tumor Surgery Market Size YoY (2017-2028) & (US$ Million)
Figure 21. Europe Metastases Spinal Tumor Surgery Market Size Market Share by Type (2017-2028)
Figure 22. Europe Metastases Spinal Tumor Surgery Market Size Market Share by Application (2017-2028)
Figure 23. Europe Metastases Spinal Tumor Surgery Market Size Share by Country (2017-2028)
Figure 24. Germany Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. France Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. U.K. Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Italy Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Russia Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Nordic Countries Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Asia-Pacific Metastases Spinal Tumor Surgery Market Size YoY (2017-2028) & (US$ Million)
Figure 31. Asia Pacific Metastases Spinal Tumor Surgery Market Size Market Share by Type (2017-2028)
Figure 32. Asia Pacific Metastases Spinal Tumor Surgery Market Size Market Share by Application (2017-2028)
Figure 33. Asia Pacific Metastases Spinal Tumor Surgery Market Size Share by Region (2017-2028)
Figure 34. China Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Japan Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. South Korea Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Southeast Asia Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. India Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Australia Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
List of Figures
Figure 40. Latin America Metastases Spinal Tumor Surgery Market Size YoY (2017-2028) & (US$ Million)
Figure 41. Latin America Metastases Spinal Tumor Surgery Market Size Market Share by Type (2017-2028)
Figure 42. Latin America Metastases Spinal Tumor Surgery Market Size Market Share by Application (2017-2028)
Figure 43. Latin America Metastases Spinal Tumor Surgery Market Size Share by Country (2017-2028)
Figure 44. Mexico Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Brazil Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Middle East & Africa Metastases Spinal Tumor Surgery Market Size YoY (2017-2028) & (US$ Million)
Figure 47. Middle East and Africa Metastases Spinal Tumor Surgery Market Size Market Share by Type (2017-2028)
Figure 48. Middle East and Africa Metastases Spinal Tumor Surgery Market Size Market Share by Application (2017-2028)
Figure 49. Middle East and Africa Metastases Spinal Tumor Surgery Market Size Share by Country (2017-2028)
Figure 50. Turkey Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Saudi Arabia Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 52. UAE Metastases Spinal Tumor Surgery Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Stryker Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 54. Johnson & Johnson Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 55. Heraeus Medical Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 56. Smith & Nephew Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 57. Medtronic Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 58. Globus Medical Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 59. DJO Global Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 60. Tecres Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 61. Merit Medical Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 62. Teknimed Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 63. G-21 Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 64. OSARTIS GmbH Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 65. IZI Medical Revenue Growth Rate in Metastases Spinal Tumor Surgery Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed


★調査レポート[転移性脊椎腫瘍手術の世界市場インサイト・予測（～2028年）] (コード：QY22JLX09252)販売に関する免責事項を必ずご確認ください。
★調査レポート[転移性脊椎腫瘍手術の世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 脊椎手術用ロボットシステム＆消耗品の世界市場インサイト・予測（～2028年）
  • 世界の脊椎手術用器具市場予測2023-2029：脊椎減圧術、脊椎固定術、骨折修復、関節形成術、非固定術
  • 椎体間脊椎インプラントの世界市場インサイト・予測（～2028年）
  • 腹腔鏡下腫瘍アブレーションの世界市場インサイト・予測（～2028年）
  • 腫瘍冷凍アブレーション装置の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆